Chieh‐Lin Fu
Impact in
- Nephrology top 1%
- Renal Diseases and Glomerulopathies
- Immunology top 2%
- Complement system in diseases
Papers in
- Genetics 11
- Chronic Lymphocytic Leukemia Research 5
- Hemoglobinopathies and Related Disorders 4
-
- Multiple Myeloma Research and Treatments 5
- Blood groups and transfusion 2
- Co-authors
- Russell P. Rother (6 shared papers)Peter Hillmen (6 shared papers)Hubert Schrezenmeier (4 shared papers)Neal S. Young (3 shared papers)Jaroslaw P. Maciejewski (3 shared papers)Jörg Schubert (3 shared papers)Robert A. Brodsky (2 shared papers)Antonio M. Risitano (2 shared papers)
- Journals
- Blood (6 papers)Leukemia Research (1 paper)Leukemia (1 paper)American Journal of Hematology (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Chieh‐Lin Fu
17 papers receiving 1.5k citations
Chieh‐Lin Fu's Hit Papers
Peers
Comparison fields: 5 of 64
- Nephrology 579
- Immunology 1.3k
- Transplantation 148
- Hematology 472
- Physiology 179
Countries citing papers authored by Chieh‐Lin Fu
This map shows the geographic impact of Chieh‐Lin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieh‐Lin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieh‐Lin Fu more than expected).
Fields of papers citing papers by Chieh‐Lin Fu
This network shows the impact of papers produced by Chieh‐Lin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieh‐Lin Fu. The network helps show where Chieh‐Lin Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chieh‐Lin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Hit paper breakdown → | 2006 | 888 |
| 2 | 2007 | 460 | |
| 3 | 2010 | 144 | |
| 4 | 2020 | 17 | |
| 5 | 2007 | 13 | |
| 6 | 2002 | 13 | |
| 7 | 2006 | 8 | |
| 8 | 2021 | 7 | |
| 9 | 2018 | 4 | |
| 10 | 2007 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2023 | 0 | |
| 19 | 2025 | 0 |
About Chieh‐Lin Fu
Chieh‐Lin Fu is a scholar working on Genetics, Hematology, Immunology, Oncology and Pathology and Forensic Medicine, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Complement system in diseases (7 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Renal Diseases and Glomerulopathies (3 papers), Blood groups and transfusion (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Nephrology (579 citations), Immunology (1.3k citations), Transplantation (148 citations), Hematology (472 citations) and Physiology (179 citations). Chieh‐Lin Fu has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Russell P. Rother, Peter Hillmen, Hubert Schrezenmeier, Neal S. Young, Jaroslaw P. Maciejewski, Jörg Schubert, Robert A. Brodsky, Antonio M. Risitano, Modupe Elebute and Paul Browne. Their work appears in journals such as Blood, Leukemia Research, Leukemia, American Journal of Hematology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.